P477 In vitro synergy of combination therapy against antifungal-resistant Candida spp. isolated from captive bottlenose dolphins ( Tursiops truncatus )

Poster session 1, September 21, 2022, 12:30 PM - 1:30 PM The study aimed to evaluate antifungal resistance in Candida spp. isolated from captive bottlenose dolphins ( Tursiops truncatus ). Due to the need to find a therapy for symptomatic animals and to the presence of azole-resistant isolates, in v...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medical mycology (Oxford) 2022-09, Vol.60 (Supplement_1)
Hauptverfasser: Matteucci, Giorgia, Biancani, Barbara, Binanti, Diana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Poster session 1, September 21, 2022, 12:30 PM - 1:30 PM The study aimed to evaluate antifungal resistance in Candida spp. isolated from captive bottlenose dolphins ( Tursiops truncatus ). Due to the need to find a therapy for symptomatic animals and to the presence of azole-resistant isolates, in vitro synergy of 3 antifungal combinations has been assayed. A total of seven captive bottlenose dolphins were examined. Two dolphins showed mild aspecific symptoms, one was receiving nystatin due to gastric candidiasis, and the other four animals were asymptomatic. The presence of Candida spp. was investigated in fecal, gastric fluid, and blow samples from each dolphin twice. Samples were cultured on Sabouraud Dextrose Agar and ChromAgar Candida at 30°C for 5 days. CHROMagar colonies consistent with Candida spp. were identified. Susceptibility tests were performed according to CLSI standard with amphotericin B (AB), 5-flucytosine (FC), itraconazole (IZ), fluconazole (FZ), miconazole (MCZ), posaconazole (PZ), voriconazole (VOR), caspofungin (CAS), anidulafungin (AND), and micafungin (MF). In addition, minimum inhibitory concentration (MIC) for nystatin (NYS) and terbinafine (TER) was determined. Based on the most common therapies in dolphins, assessment of the interaction between FZ and TER, VOR and TER, and VOR and NYS was carried out determining the fractional inhibitory concentration (FIC) index by checkerboard assay. Out of 42 samples analyzed, 30 were positive for Candida spp. identified as C. albicans ( n =21), C. tropicalis ( n =6), and C. glabrata ( n =3). All the isolates showed resistance to azoles. A total of 50% of the isolates showed resistance to FC and 23.3% to AMB. No isolate showed resistance to echinocandins. MIC values ranged from 16 to 128 µg/ml for TER (arithmetic mean 107.8 µg/ml) and from 8 to 128 µg/ml (arithmetic mean 51.8 µg/ml) for NYS. The FIC index value for FLU and TER showed a synergistic effect on 71.4% and an additive effect on 28.6% of the tested isolates. For VOR and TER an additive effect on 71.4% and a synergistic effect on 28.6% of the isolates were detected. For VOR and NYS an antagonistic effect on 71.4% and an additive effect on 28.6% of the isolates were detected. According to the results, combination therapy with FLU and TER was started. Symptoms resolved completely. Candida spp. has been isolated from mucous membranes of free-living asymptomatic dolphins. However, a high load of Candida spp. may cause clinical signs. As
ISSN:1369-3786
1460-2709
DOI:10.1093/mmy/myac072.P477